Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2021-07-01
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Hearing Aid Benefit
NCT05198713
Evaluation of Investigational Hearing Instrument Features
NCT06710236
A Comparison of a Currently Marketed Hearing Aid Programmed With Two Different Fitting Methods
NCT03498274
In Field Performance of a Hearing Aid Transducer
NCT04787055
Preference Comparisons for Algorithms to Hear Speech
NCT05561335
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A-B-A
Participants will be fit with hearing instruments A and B in the following order:
Hearing instrument A Hearing instrument B Hearing instrument A
Receiver-in-canal hearing instrument; Manufacturer A
Commercially available receiver-in-canal hearing instrument from manufacturer A
Receiver-in-canal hearing instrument; Manufacturer B
Commercially available receiver-in-canal hearing instrument from manufacturer B
B-A-B
Participants will be fit with hearing instruments A and B in the following order:
Hearing instrument B Hearing instrument A Hearing instrument B
Receiver-in-canal hearing instrument; Manufacturer A
Commercially available receiver-in-canal hearing instrument from manufacturer A
Receiver-in-canal hearing instrument; Manufacturer B
Commercially available receiver-in-canal hearing instrument from manufacturer B
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Receiver-in-canal hearing instrument; Manufacturer A
Commercially available receiver-in-canal hearing instrument from manufacturer A
Receiver-in-canal hearing instrument; Manufacturer B
Commercially available receiver-in-canal hearing instrument from manufacturer B
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Current hearing aid user
Exclusion Criteria
* Inability to travel to study appointments or to complete questionnaires.
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sonova AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Phonak Audiology Research Center
Aurora, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SRF-311
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.